Showing results (31-40 of 144) with videos related to
Sort By:
Pageof 15
Psychopharmacology|July 24, 2009
Selective effects of benzodiazepines on the acquisition of conditioned taste aversion compared to attenuation of neophobia in C57BL/6 miceZsuzsanna Callaerts-Vegh, Daniel Hoyer, Peter H KellyJournal of Internal Medicine|January 19, 2022
Hypocretins (orexins): The ultimate translational neuropeptidesLaura H Jacobson, Daniel Hoyer, Luis de LeceaCurrent Topics in Behavioral Neurosciences|December 3, 2016
Orexin OX2 Receptor Antagonists as Sleep AidsLaura H Jacobson, Sui Chen, Sanjida Mir, et al.Psychopharmacology|September 29, 2004
Paroxetine combined with a 5-HT(1A) receptor antagonist reversed reward deficits observed during amphetamine withdrawal in ratsAthina Markou, Amanda A Harrison, Jessica Chevrette, et al.Neuropeptides|June 12, 2010
Somatostatin-28 modulates prepulse inhibition of the acoustic startle response, reward processes and spontaneous locomotor activity in ratsSvetlana Semenova, Daniel Hoyer, Mark A Geyer, et al.The Behavioral and Brain Sciences|July 7, 2022
The labelled container: Conceptual development of social group representationsRebekah A Gelpi, Suraiya Allidina, Daniel Hoyer, et al.European Journal of Pharmacology|February 23, 2002
Pharmacological characterisation of the goldfish somatostatin sst5 receptorCaroline Nunn, Dominik Feuerbach, Xinwei Lin, et al.Molecular and Cellular Endocrinology|February 5, 2008
Pharmacological profile of somatostatin and cortistatin receptorsSandra Siehler, Caroline Nunn, Jason Hannon, et al.Neuroscience Letters|February 23, 2007
JN403, in vitro characterization of a novel nicotinic acetylcholine receptor alpha7 selective agonistDominik Feuerbach, Joachim Nozulak, Kurt Lingenhoehl, et al.Molecular and Cellular Endocrinology|June 1, 2002
Identification and characterization of a type five-like somatostatin receptor in goldfish pituitaryXinwei Lin, Caroline Nunn, Daniel Hoyer, et al.Pageof 15